Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data

Serum ?2 microglobulin (?2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients

(2011) K. Yokoyama et al.   CLINICAL NEPHROLOGY

No need for an ‘‘expiry date’’ in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the world

(2010)   INTERNATIONAL UROLOGY AND NEPHROLOGY

The Use of Biocompatible Solutions Does Not Prevent Development of Encapsulating Peritoneal Sclerosis

(2010) M. Tejde et al.   PERITONEAL DIALYSIS INTERNATIONAL

EARLY DIAGNOSTIC MARKERS FOR ENCAPSULATING PERITONEAL SCLEROSIS: A CASE-CONTROL STUDY

(2010) D. E. Sampimon et al.   PERITONEAL DIALYSIS INTERNATIONAL

Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis rates

(2009) Shruti N. Tapiawala et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

No need for an “expiry date” in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis

(2009) Guido Garosi et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

THALIDOMIDE SUPPRESSES SCLEROSING ENCAPSULATING PERITONITIS IN A RAT EXPERIMENTAL MODEL

(2009) Stefania Mondello et al.   SHOCK

Successful Treatment of Encapsulating Peritoneal Sclerosis With Immunosuppressive Therapy

(2008) Jean-Philippe Lafrance et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients

(2008) I. Kolesnyk et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis

(2008) W. Fang et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The Role of the TGF/Smad Signaling Pathway in Peritoneal Fibrosis Induced by Peritoneal Dialysis Solutions

(2008) Qiang Yao et al.   NEPHRON EXPERIMENTAL NEPHROLOGY